Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. KEGG DRUG DrugBank 薬物名（臨床試験情報から抽出） KEGG GENES KEGG PATHWAY 指定難病告示番号
1 Urea 1件: Urea1件: Urea; --2件: 72, 251
2 Uracil -0件: ---
3 Ubenimex 1件: Ubenimex1件: Ubenimex; 1件: ANPEP 💬4件: Glutathione metabolism, Hematopoietic cell lineage, Metabolic pathways, Renin-angiotensin system 💬1件: 86
4 Ursodiol 1件: Ursodeoxycholic acid4件: UDCA; Ursodeoxycholic acid; Ursodiol; UrsoFalk; 1件: NR1H4 💬1件: Bile secretion 💬14件: 6, 8, 20, 46, 67, 84, 93, 94, 95, 96, 97, 234, 296, 299
5 Ubidecarenone 1件: Ubidecarenone3件: Coenzyme Q-10; Coenzyme Q10; CoQ10; --13件: 2, 5, 6, 8, 10, 18, 46, 57, 86, 113, 193, 214, 215
6 Urapidil -0件: ---
7 Urea C13 1件: Urea1件: Urea; --2件: 72, 251
8 Undecylenic acid -0件: ---
9 Urokinase -0件: ---
10 Ulinastatin -0件: ---
11 Uracil mustard -0件: ---
12 Urofollitropin -0件: ---
13 Urokinase alfa -0件: ---
14 Ulobetasol -0件: ---
15 Unoprostone 1件: Unoprostone1件: Unoprostone; 1件: PTGFR 💬3件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway 💬1件: 90
16 Ustekinumab 1件: Ustekinumab2件: Stelara; Ustekinumab; 3件: IL12A,
IL12B,
IL23A 💬		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬17件: 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271
17 Ulipristal 1件: Ulipristal1件: Ulipristal; 1件: PGR 💬5件: Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬1件: 10
18 Uracil -0件: ---
19 Ulimorelin -0件: ---
20 Umirolimus -0件: ---
21 Urelumab -0件: ---
22 Uridine triacetate 1件: Uridine triacetate1件: Tri-O-acetyluridine; --1件: 21
23 Usistapide -0件: ---
24 Udenafil 1件: Udenafil1件: Udenafil; 1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬2件: 86, 210
25 Umeclidinium -0件: ---
26 Ulodesine -0件: ---
27 Umifenovir -0件: ---
28 Ubrogepant -0件: ---
29 Uprosertib -0件: ---
30 Upadacitinib 1件: Upadacitinib2件: Rinvoq; Upadacitinib; 1件: JAK1 💬27件: Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬8件: 40, 41, 46, 49, 96, 97, 107, 271
31 Uprifosbuvir -0件: ---
32 Utomilumab -0件: ---
33 Ulixertinib -0件: ---
34 Ublituximab 1件: Ublituximab1件: UBLITUXIMAB; 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13
35 Umbralisib -0件: ---
36 Uproleselan -0件: ---